V022-5520 Screening compound: N-[(4-fluorophenyl)methyl]-N-[4-({[2-(piperidin-1-yl)ethyl]carbamoyl}methyl)phenyl]benzamide

V022-5520 Screening compound: N-[(4-fluorophenyl)methyl]-N-[4-({[2-(piperidin-1-yl)ethyl]carbamoyl}methyl)phenyl]benzamide
V022-5520 Screening compound: N-[(4-fluorophenyl)methyl]-N-[4-({[2-(piperidin-1-yl)ethyl]carbamoyl}methyl)phenyl]benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V022-5520
N-[(4-fluorophenyl)methyl]-N-[4-({[2-(piperidin-1-yl)ethyl]carbamoyl}methyl)phenyl]benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V022-5520

Molecular Formula

C29H32FN3O2 (C29 H32 FN3 O2)

Compound Name

N-[(4-fluorophenyl)methyl]-N-[4-({[2-(piperidin-1-yl)ethyl]carbamoyl}methyl)phenyl]benzamide

IUPAC name

N-[(4-fluorophenyl)methyl]-N-[4-({[2-(piperidin-1-yl)ethyl]carbamoyl}methyl)phenyl]benzamide

SMILES

O=C(Cc(cc1)ccc1N(Cc(cc1)ccc1F)C(c1ccccc1)=O)NCCN1CCCCC1

InChI

InChI=1S/C29H32FN3O2/c30-26-13-9-24(10-14-26)22-33(29(35)25-7-3-1-4-8-25)27-15-11-23(12-16-27)21-28(34)31-17-20-32-18-5-2-6-19-32/h1,3-4,7-16H,2,5-6,17-22H2,(H,31,34)

InChI Key

YFRLPRKKOMWJSB-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19910523

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

473.59

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

4.033

Distribution Coefficient, logD

2.240

Water Solubility, LogSw

-4.00

Polar Surface Area

43.613

Acid Dissociation Constant (pKa)

13.37

Base Dissociation Constant (pKb)

9.19

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

31.00

V022-5520 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
Targets:
  • GPCR
  • Ion Channels

References: we are preparing a list of scientific research reports with V022-5520 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V022-5520?
Check Price and Availability of V022-5520, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V022-5520 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V022-5520
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V022-5520
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V022-5520 available by request